(PharmaNewsWire.Com, January 29, 2020 ) The growth in specialty PACS market is driven mainly by the increasing geriatric population and subsequent growth in the incidence of various diseases, advantages associated with specialty PACS, government initiatives to increase the adoption of healthcare IT solutions, growing investments in medical imaging, rising adoption of medical imaging IT solutions, and increasing use of imaging equipment.
The Specialty PACS Market is projected to reach USD 3.5 billion in 2024 from USD 2.6 billion in 2019, at a CAGR of 6.0%.
+ Market Dynamics
+ Drivers
+ Growing Government Initiatives to Increase the Adoption of Healthcare It Solutions
+ Growing Investments in Medical Imaging
+ Growing Adoption of Medical Imaging It Solutions
+ Increasing Use of Imaging Equipment
+ Increasing Geriatric Population and the Subsequent Growth in the Incidence of Various Diseases
“The Ophthalmology PACS segment is projected to grow at the highest CAGR during the forecast period.”
The specialty PACS market is segmented into radiology PACS, cardiology PACS, pathology PACS, ophthalmology PACS, orthopedics PACS, oncology PACS, dermatology PACS, neurology PACS, endoscopy PACS, women’s health PACS, and other specialty PACS.
“Based on the component, the services segment is projected to grow at the highest CAGR during the forecast period.”
The specialty PACS market is segmented into software, services, and hardware. In 2018, the software segment accounted for the largest specialty PACS market share. With the consistent increase in the healthcare imaging volumes, there is a growing demand for PACS software.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
